Rumalon ampoule 1ml №25

Adverse Effects

Determination of the frequency of adverse reactions (according to the WHO classification): very often (≥1 / 10), often (from ≥1 / 100 to <1/10), infrequently (from ≥1 / 1000 to <1/100), rarely (from ≥1 / 10,000 to <1/1000), very rarely (<1/10 000), the frequency is unknown (it was not possible to establish the frequency of occurrence based on available data).

On the part of the immune system: rarely - allergic reactions, incl. anaphylactoid reactions, anaphylactic shock.

If these or any other side effects appear, the patient should stop using the drug and inform the attending physician.

Contraindications

- hypersensitivity to the drug;

- rheumatoid arthritis;

- age up to 18 years;

- pregnancy;

- breastfeeding period;

- Use in women of reproductive age who do not comply with reliable methods of contraception.

Pregnancy and Breastfeeding

The use of the drug during pregnancy and during breastfeeding is contraindicated (due to the lack of information about the use of the drug in these groups of patients).

Special notes

With simultaneous use with indirect anticoagulants, antiplatelet agents and fibrinolytics, frequent monitoring of blood coagulation parameters is necessary.

Influence on ability to drive vehicles and mechanisms

The use of the drug does not affect the ability to perform potentially hazardous activities that require increased concentration of attention and speed of psychomotor reactions (driving, working with moving mechanisms, the work of the dispatcher and the operator).

Overdosage

So far, cases of overdose are not registered.

Drug Interactions

Drug Rumalon ^® can be used simultaneously with NSAIDs and SCS.

With simultaneous use with indirect anticoagulants, antiplatelet agents and fibrinolitikov may increase their action.

Storage conditions

The drug should be stored out of the reach of children, protected from light at a temperature not higher than 25 ° C. Shelf life - 5 years.